Study: PrEP, Taken Regularly, 100 Percent Effective

By BTL Staff

Scientists at the International AIDS Conference in Sydney, Australia, released the results of an open label study of Pre-Exposure Prophylaxis this week, which found that regular dosing of the drug Truvada is 100 percent effective in preventing HIV-negative people from becoming infected with the virus.

AIDS Map reports the study, released in The Lancelet medical journal in conjunction with the report on the study at the conference, found that people who had blood concentration levels equivalent to taking Truvada at least four times a week. That, researchers say, resulted in 100 percent protection from HIV infection.

The study did find adherence to taking the drugs was low - only one-third of participants had a blood level equal to four or more weekly doses. Adherence was also lower in younger men who have sex with men, a key demographic in need of the drug, experts from both the CDC and the World Health Organization have said.

Learn more at http://www.prep4itnow.com


  • Latest News

Enter To Win

Enter contests to win great prizes like CDs, DVDs, concert tickets and more

Special Section: World AIDS Day
Study Finds Significant Racial Disparities For HIV Infection Among Black And White MSM

A study published in the journal The Lancet HIV reports that there is a significant disparity in HIV prevalence between black and white men who have sex with men. The study was published on Nov. 18 and found a startling 32 percent prevalence rate for black men who have sex with men, compared with only eight percent for white men who have sex with men.

View More World AIDS Day
This Week's Issue

Download or view this week's print issue today!